Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Robotic Or Endoscopic Nipple Sparing Mastectomy

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1
Active Not Recruiting1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07292246Not ApplicableRecruiting

A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)

NCT04585074Active Not Recruiting

Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery

NCT03982446CompletedPrimary

Germline Mutations in Pancreatic Adenocarcinoma

Showing all 3 trials

Research Network

Common Treatments

  • Robotic Or Endoscopic Nipple Sparing Mastectomy1
  • Conventional Mastectomy Including Nipple Sparing Mastectomy Skin Sparing Mastectomy1
  • Endoscopic Nipple Sparing Mastectomy1
  • Handx Endoscopic Instrument1
  • Mutations1

Active Sponsors

  • Hellenic Cooperative Oncology Group1
  • Severance Hospital1
  • Vasileios Kalles1

Top Investigators

Related Conditions

  • Breast Neoplasms2
  • Hereditary Breast Carcinoma1
  • Benign Breast Disease1
  • Dcis1
  • Brca 1 Gene Mutation1

Activity Timeline